Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, April 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Aesica Introduces Aseptic Micro Dosing Capabilities at Nottingham Site
Tuesday, November 05, 2013
New technology (3P Fill2Weight) reduces development cycle and can be used with capsules, vials, inhalers, injectables, blisters and even high potents.

Avoiding Sample Loss During Evaporative Drying
Tuesday, November 05, 2013
Dri-Pure® technology from Genevac offers significant benefits to scientists, especially those working in synthesis and purification.

New Method for Microcarrier Cell Culture using TAP’s ambr Micro Bioreactors
Thursday, October 31, 2013
Saves time optimizing process conditions enabling rapid vaccine production.

Turn-key Packages for Process Scale Reactions
Monday, October 21, 2013
New ReactoMate Pilot jacketed reaction vessel from Asynt.

Rocket 4D Receives Positive Customer Commentary
Thursday, October 10, 2013
A fully automated system for automatic drying of very large volumes up to 100 litres.

New for World Vaccine Congress TAP’s Cellmate Mk9 Automated Cell Culture System
Thursday, October 10, 2013
Designed for safe, high-throughput viral vaccine production.

Mettler Toledo Launches New Analytical Balance Line
Thursday, October 03, 2013
Intelligent features ensure compliance and process security.

Product Launches at Lab Innovations 2013
Tuesday, October 01, 2013
Over 40% of exhibitors at Lab Innovations 2013 are using the show to launch new technologies and services into the UK.

New Diameter Core-Shell Column for Purification
Monday, September 30, 2013
New Kinetex® core-shell HPLC prep column choice enables higher loads for pharmaceutical lab-scale purification.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 879
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv